QOF database

Home | News | Downloads
DR. LAWSON & PARTNERS

DR. LAWSON & PARTNERS

PRIORY SURGERY, PRIORY SURGERY, 26 HIGH STREET, HOLYWOOD

HF 4

The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.

IndicatorYearNumeratorDenominatorRatioCentile
HF 4 2010 32 50 64.0%
HF 4 2011 33 51 64.7%
HF 4 2012 27 38 71.1%
HF 4 2013 27 36 75.0%
HF004 2014 0 0 NA%
HF004 2015 None None NA%
HF004 2016 10 10 100.0%
HF004 2017 17 19 89.5%
HF004 2018 23 25 92.0%
HF004 2019 26 31 83.9%
HF004 2020 24 25 96.0%
HF004 2021 40 41 97.6%